Mark Your Calendars: Sandy Spring Bancorp Inc. to Webcast Third Quarter Earnings Conference Call on October 21, 2024

Sandy Spring Bancorp, Inc. to Announce Third Quarter Earnings Olney, Md., Oct. 01, 2024 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (Nasdaq: SASR) has announced that it will be releasing its third quarter earnings on Monday, October 21, 2024. Investors and stakeholders are eagerly anticipating the results of the company’s performance during this period. The…

Read More

Clever, Personable, and Unconventional: Hennessy Capital Investment Corp VI Announces Stockholder Approval of Business Combination Deadline Extension

Welcome to the Future of Investment Hennessy Capital Investment Corp. VI Extends Business Combination Date New York, Oct. 01, 2024 In a recent announcement, Hennessy Capital Investment Corp. VI (NASDAQ: HCVI) revealed a significant update regarding the timeline for its initial business combination. The Company’s stockholders have voted in favor of amending the Charter to…

Read More

PayPoint plc Director Discloses Shareholding as PDMR

PayPoint Plc Notifications of Transactions by PDMRs The PayPoint Plc Share Incentive Plan – Dividend Reinvestment Notification of Dealing Form On 1 October 2024, PayPoint Plc received notifications of transactions by Persons Discharging Managerial Responsibilities (PDMRs) related to the reinvestment of the final cash dividend paid by the Company on 27 September 2024. The second…

Read More

Discovering New Horizons: Silexion Therapeutics Shares Exciting Findings from SIL-204 Preclinical Studies

Exciting New Developments in Cancer Treatment: Silexion Therapeutics Announces Breakthrough in RNAi Therapies A New Hope for KRAS-driven Cancers It is with great excitement that Silexion Therapeutics Corp. has announced new preclinical findings for SIL-204, its second-generation siRNA candidate. These findings come after the optimization of its extended-release formulation, marking a significant milestone in the…

Read More

Breaking News: Bionomics Limited Plans to Move Headquarters to the United States

Bionomics Limited Announces Intention to Re-Domicile to the United States ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”), a clinical-stage biotechnology company developing novel, potential first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system disorders with high unmet medical…

Read More